Danaher Corporation $DHR Shares Bought by Banque Pictet & Cie SA

Key Points

• Banque Pictet & Cie SA increased its Danaher stake by 23.4% in the third quarter, purchasing 27,534 additional shares and bringing its holdings to 145,326 shares valued at approximately $32.2 million.
• Danaher reported quarterly revenue of $6.26 billion and earnings of $1.94 per share, exceeding analyst expectations, while revenue grew 5.5% year over year. The company also declared a quarterly dividend of $0.40 per share, equivalent to a 0.7% annualized yield.
• Analysts remain generally positive, with the stock carrying a “Moderate Buy” consensus rating and an average price target of $235.41; Danaher shares recently traded at $228.87.

Banque Pictet & Cie SA lifted its position in Danaher Corporation (NYSE:DHR - Free Report) by 23.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 145,326 shares of the conglomerate's stock after purchasing an additional 27,534 shares during the period. Banque Pictet & Cie SA's holdings in Danaher were worth $32,197,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in DHR. Marquette Asset Management LLC lifted its stake in Danaher by 192.1% in the 3rd quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate's stock worth $25,000 after purchasing an additional 73 shares in the last quarter. N.E.W. Advisory Services LLC acquired a new stake in shares of Danaher in the second quarter valued at approximately $25,000. Main Street Group LTD purchased a new position in Danaher during the first quarter worth approximately $25,000. Field & Main Bank purchased a new position in Danaher during the second quarter worth approximately $29,000. Finally, Evolution Wealth Management Inc. boosted its stake in Danaher by 208.0% during the first quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate's stock worth $29,000 after buying an additional 104 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Trading Down 1.1%

NYSE DHR opened at $228.87 on Friday. The firm's fifty day moving average is $214.04 and its two-hundred day moving average is $195.97. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The firm has a market cap of $160.89 billion, a PE ratio of 40.65, a P/E/G ratio of 2.91 and a beta of 0.76.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion during the quarter, compared to analysts' expectations of $6.12 billion. During the same quarter last year, the business earned $0.77 EPS. The business's revenue was up 5.5% on a year-over-year basis. Analysts expect that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Wednesday, September 30th. Danaher's dividend payout ratio is 28.42%.

Analysts Set New Price Targets

Several research firms have recently commented on DHR. The Goldman Sachs Group raised their price target on Danaher from $210.00 to $250.00 and gave the stock a "buy" rating in a research report on Monday, September 21st. Weiss Ratings raised Danaher from a "hold (c-)" rating to a "hold (c)" rating in a research report on Wednesday, September 16th. Stifel Nicolaus decreased their price objective on Danaher from $260.00 to $220.00 and set a "buy" rating for the company in a research note on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and set a $240.00 price objective on shares of Danaher in a research report on Wednesday, July 22nd. Finally, Royal Bank Of Canada upped their target price on shares of Danaher from $215.00 to $250.00 and gave the stock an "outperform" rating in a research note on Monday, October 5th. Two research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have issued a Hold rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $235.41.

About Danaher

Danaher Corporation NYSE: DHR is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.